🇺🇸 FDA
Patent

US 12145944

Imidazopyrimidines as EED inhibitors and the use thereof

granted A61KA61K45/06A61P

Quick answer

US patent 12145944 (Imidazopyrimidines as EED inhibitors and the use thereof) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Nov 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Nov 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K45/06, A61P, A61P35/00